Eye discharge and drugs of ingredients of macitentan (a real world drug study)
Summary:
Eye discharge is found among people who take drugs with ingredients of macitentan, especially for people who are female, 60+ old , have been taking the drugs for 2 - 5 years. This phase IV clinical study is created by eHealthMe based on reports of 75,003 people who have side effects when taking drugs with ingredients of macitentan from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Macitentan, Opsumit.
75,003 people reported to have side effects when taking drugs with ingredients of macitentan.
Among them, 21 people (0.03%) have Eye discharge
What is Eye discharge?
Eye discharge is found to be associated with 688 drugs and 803 conditions by eHealthMe. Check the latest studies of Eye discharge.
Number of reports submitted per year:

Time on drugs with ingredients of macitentan when people have Eye discharge *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Eye discharge when taking drugs with ingredients of macitentan *:
- female: 66.67 %
- male: 33.33 %
Age of people who have Eye discharge when taking drugs with ingredients of macitentan *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 21.05 %
- 30-39: 5.26 %
- 40-49: 0.0 %
- 50-59: 36.84 %
- 60+: 36.84 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 18 people, 85.71%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 14.29%
- Oedema (fluid collection in tissue): 2 people, 9.52%
- Atrial Tachycardia (rhythm disturbance that arises in the atria): 2 people, 9.52%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.76%
- Pain: 1 person, 4.76%
- Anaemia (lack of blood): 1 person, 4.76%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Uptravi: 6 people, 28.57%
- Adempas: 5 people, 23.81%
- Eliquis: 4 people, 19.05%
- Remodulin: 4 people, 19.05%
- Tracleer: 3 people, 14.29%
- Lasix: 3 people, 14.29%
- Xarelto: 3 people, 14.29%
- Aldactone: 2 people, 9.52%
- Apixaban: 2 people, 9.52%
- Triamterene And Hydrochlorothiazide: 1 person, 4.76%
Other side effects people have besides Eye discharge *:
You may use this to check any potential undetected side effects.
- Diarrhea: 9 people, 42.86%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 33.33%
- Nausea (feeling of having an urge to vomit): 7 people, 33.33%
- Heart Rate Increased: 7 people, 33.33%
- Cough: 6 people, 28.57%
- Hospitalisation: 6 people, 28.57%
- Weight Increased: 6 people, 28.57%
- Dizziness: 5 people, 23.81%
- Dry Throat: 5 people, 23.81%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 5 people, 23.81%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of macitentan, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on macitentan. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pregabalin cause Neoplasm Malignant? - a second ago
- Cetirizine Hydrochloride and Dizziness for Men aged 50-59 - 5 seconds ago
- Cetirizine Hydrochloride and Light-Headedness When Standing Up for Men aged 50-59 - 5 seconds ago
- Cetirizine Hydrochloride and Lightheadedness for Men aged 50-59 - 6 seconds ago
- Cetirizine Hydrochloride and Vertigo for Men aged 50-59 - 6 seconds ago
- Cetirizine Hydrochloride and Lightheadedness - Dizzy for Men aged 50-59 - 6 seconds ago
- Cetirizine Hydrochloride and Loss Of Balance for Men aged 50-59 - 7 seconds ago
- Drug interactions of Arnuity Ellipta and Mirtazapine - 9 seconds ago
- Malaise and drugs of ingredients of interferon beta 1a - 12 seconds ago
- Drug interactions of Anoro Ellipta and Loratadine - 21 seconds ago